20664740|t|Celecoxib does not attenuate the antiplatelet effects of aspirin and clopidogrel in healthy volunteers.
20664740|a|BACKGROUND AND OBJECTIVES: The prevalence of arthritis, which is often treated with celecoxib, is high in patients with coronary artery disease. Furthermore, celecoxib has been reported to reduce restenosis after coronary stenting by inhibiting expression of the proto-oncogene Akt. A concern is that celecoxib increases thrombogenicity by inhibiting the synthesis of prostacyclin in endothelial cells. However, it is not known whether the administration of celecoxib will attenuate the antiplatelet effects of aspirin and clopidogrel, which are used after stenting. We addressed this gap in our knowledge. SUBJECTS AND METHODS: We recruited healthy volunteers (n=40) and randomized them into five subgroups (n=8 for each group: aspirin, celecoxib, aspirin+celecoxib, aspirin+clopidogrel, and aspirin+clopidogrel+celecoxib). Each subject received their medications for 6 days and blood samples were taken on day 0 and day 7. Celecoxib (200 mg twice a day), and/or aspirin (100 mg daily), and/or clopidogrel (75 mg daily) were administered. We compared platelet function among subgroups using light transmittance aggregometry and arachidonic acid metabolite assays. RESULTS: Celecoxib treatment alone did not significantly affect platelet aggregation. The reduction in adenosine diphosphase (ADP)-induced platelet aggregation by aspirin+clopidogrel was not affected by addition of celecoxib (31.3+/-6.9% vs. 32.4+/-12.2%, p=0.83). Inhibition of collagen-induced platelet aggregation by aspirin+clopidogrel was not affected by addition of celecoxib (47.6+/-13.4% vs. 51.6+/-3.7%, p=0.69). Drug-induced changes in prostacyclin and thromboxane levels did not differ among treatment groups. CONCLUSION: Celecoxib treatment does not interfere with the antiplatelet effects of aspirin or clopidogrel, suggesting that celecoxib can be safely administered in combination with dual antiplatelet therapy in patients with coronary stenting without increased thrombogenicity.
20664740	0	9	Celecoxib	Chemical	MESH:D000068579
20664740	57	64	aspirin	Chemical	MESH:D001241
20664740	69	80	clopidogrel	Chemical	MESH:D000077144
20664740	149	158	arthritis	Disease	MESH:D001168
20664740	188	197	celecoxib	Chemical	MESH:D000068579
20664740	210	218	patients	Species	9606
20664740	224	247	coronary artery disease	Disease	MESH:D003324
20664740	262	271	celecoxib	Chemical	MESH:D000068579
20664740	300	310	restenosis	Disease	MESH:D023903
20664740	382	385	Akt	Gene	207
20664740	405	414	celecoxib	Chemical	MESH:D000068579
20664740	472	484	prostacyclin	Chemical	MESH:D011464
20664740	562	571	celecoxib	Chemical	MESH:D000068579
20664740	615	622	aspirin	Chemical	MESH:D001241
20664740	627	638	clopidogrel	Chemical	MESH:D000077144
20664740	833	840	aspirin	Chemical	MESH:D001241
20664740	842	851	celecoxib	Chemical	MESH:D000068579
20664740	853	860	aspirin	Chemical	MESH:D001241
20664740	861	870	celecoxib	Chemical	MESH:D000068579
20664740	872	879	aspirin	Chemical	MESH:D001241
20664740	880	891	clopidogrel	Chemical	MESH:D000077144
20664740	897	904	aspirin	Chemical	MESH:D001241
20664740	905	916	clopidogrel	Chemical	MESH:D000077144
20664740	917	926	celecoxib	Chemical	MESH:D000068579
20664740	1029	1038	Celecoxib	Chemical	MESH:D000068579
20664740	1068	1075	aspirin	Chemical	MESH:D001241
20664740	1099	1110	clopidogrel	Chemical	MESH:D000077144
20664740	1233	1249	arachidonic acid	Chemical	MESH:D016718
20664740	1278	1287	Celecoxib	Chemical	MESH:D000068579
20664740	1333	1353	platelet aggregation	Disease	MESH:D001791
20664740	1372	1393	adenosine diphosphase	Chemical	-
20664740	1395	1398	ADP	Chemical	-
20664740	1408	1428	platelet aggregation	Disease	MESH:D001791
20664740	1432	1439	aspirin	Chemical	MESH:D001241
20664740	1440	1451	clopidogrel	Chemical	MESH:D000077144
20664740	1484	1493	celecoxib	Chemical	MESH:D000068579
20664740	1565	1585	platelet aggregation	Disease	MESH:D001791
20664740	1589	1596	aspirin	Chemical	MESH:D001241
20664740	1597	1608	clopidogrel	Chemical	MESH:D000077144
20664740	1641	1650	celecoxib	Chemical	MESH:D000068579
20664740	1715	1727	prostacyclin	Chemical	MESH:D011464
20664740	1732	1743	thromboxane	Chemical	MESH:D013931
20664740	1802	1811	Celecoxib	Chemical	MESH:D000068579
20664740	1874	1881	aspirin	Chemical	MESH:D001241
20664740	1885	1896	clopidogrel	Chemical	MESH:D000077144
20664740	1914	1923	celecoxib	Chemical	MESH:D000068579
20664740	2000	2008	patients	Species	9606
20664740	Cotreatment	MESH:D000068579	MESH:D000077144
20664740	Negative_Correlation	MESH:D000068579	MESH:D001791
20664740	Negative_Correlation	MESH:D000068579	MESH:D011464
20664740	Negative_Correlation	MESH:D000068579	MESH:D001168
20664740	Negative_Correlation	MESH:D000068579	207
20664740	Negative_Correlation	MESH:D000068579	MESH:D023903
20664740	Negative_Correlation	MESH:D000068579	MESH:D003324
20664740	Cotreatment	MESH:D000077144	MESH:D001241
20664740	Cotreatment	MESH:D000068579	MESH:D001241
20664740	Negative_Correlation	MESH:D000077144	MESH:D001791
20664740	Negative_Correlation	MESH:D001241	MESH:D001791

